Medically reviewed by Drugs.com. Last updated on May 3, 2022.
The effects of all botulinum toxin products, including prabotulinumtoxinA-xvfs, may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. PrabotulinumtoxinA-xvfs is not approved for the treatment of spasticity or any conditions other than glabellar lines
Commonly used brand name(s)
In the U.S.
- Jeuveau
Pharmacologic Class: PrabotulinumtoxinA
Uses for prabotulinumtoxina-xvfs
PrabotulinumtoxinA-xvfs is used cosmetically to temporarily improve the appearance of deep facial lines or wrinkles between the eyebrows (glabellar lines). Prabotulinumtoxina-xvfs is not approved for use in other conditions, including upper limb spasticity (muscle spasms in the upper arms) in children.
PrabotulinumtoxinA-xvfs is a botulinum toxin A product. It works on the nervous system to relax the muscles.
Prabotulinumtoxina-xvfs is available only with your doctor's prescription and will be given by your doctor.
Before using prabotulinumtoxina-xvfs
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For prabotulinumtoxina-xvfs, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to prabotulinumtoxina-xvfs or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies have not been performed on the relationship of age to the effects of prabotulinumtoxinA-xvfs in the pediatric population. Safety and efficacy have not been established.
Geriatric
Appropriate studies performed to date have not demonstrated geriatric-specific problems..
